mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
2e-05 |
mRNA |
GSK690693 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
2e-05 |
mRNA |
TAK-715 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
3e-05 |
mRNA |
QW-BI-011 |
CTRPv2 |
pan-cancer |
AAC |
0.29 |
3e-05 |
mRNA |
Bax channel blocker |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-05 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-05 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
4e-05 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
7e-05 |
mRNA |
BRD-K88742110 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
7e-05 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
7e-05 |